West Pharmaceutical Services, Inc. (WST)
WSTNYSEMedical/Dental Instruments
$413.09
0.0000 (0.00%) today
Pre-market, Nov 9, 4:00 PM ET
- Market cap
- $28.76bn
- P/E
- 44.9
- EPS, last 4 quarters
- $9.20
- Dividend yield
- –
- Day range
- –
- 52-week range
- $223.83 to $438.27
- Average volume
- 551.1k
- Previous close
- $413.09
Analysts
6 coveringBuy6 buy, 0 hold, 0 sell
Targets a year out average $478.17, +15.8% from here
Earnings
next estimate $2.27Next report
Dec 2025
+11.5%
Mar 2026
+26.8%
Jun 2026
+13.9%
Sep 2026
+22.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $805.00m | $844.90m | $872.30m | $874.50m |
| Gross profit | $303.90m | $296.40m | $329.20m | $347.40m |
| Operating income | $156.60m | $177.10m | $179.10m | $267.40m |
| Net income | $132.10m | $138.80m | $154.00m | $214.00m |
Last four quarters: revenue $3.40bn, margin 18.8%, free cash flow $453.40m
News
8 latest- Waters Expands Proteomics Reach With MOBILion Systems AcquisitionZacks · 18 hours ago
- 10x Genomics Launches Sentira AI Tool to Simplify Cell AnalysisZacks · 4 days ago
- Here's Why You Should Retain MMSI Stock in Your Portfolio for NowZacks · 4 days ago
- GE HealthCare Unveils Allia Celeo to Advance Interventional ImagingZacks · 5 days ago
- CAH Q1 Earnings & Revenues Beat Estimates on Pharma StrengthZacks · 5 days ago
- West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?Zacks · 5 days ago
- West Pharmaceutical Services Consensus Price Target Raised 12.52% to $467.89Fintel · Nov 2, 2026
- What West Pharmaceutical Services (WST) Said on Its Q3 Earnings CallMarketBeat · Oct 31, 2026
The company
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $37 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- westpharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.